vimarsana.com
  1. Home
  2. Live Updates
  3. Cardiology Department Of Wonkwang University - Breaking News

Latest Breaking News On - Cardiology department of wonkwang university - Page 1 : vimarsana.com

Hanmi Pharmaceutical s Combination Drug for Dyslipidemia Treatment, Rosuzet : Confirmed Non-inferiority Efficacy and Safety Compared to Monotherapy in The Lancet & European Heart Journal

/PRNewswire/ Hanmi Pharmaceuticals (128940.KS), a subsidiary of Hanmi Science (008930.KS) in Korea, announced that the results of large-scale clinical trial.

Soult ukpyolsiSouth koreaKim joong sunJae young choRosuzet rosuvastatinLee yong junHanmi pharmaceuticalsHanmi pharmaceutical incKorea university anam hospitalCha university college of medicineCardiology department of wonkwang universityHanmi scienceEuropean heartHanmi pharmaceuticalEuropean heart journalSeverance hospital

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.